National Bank of Canada
LAB icon

National Bank of Canada’s Standard BioTools LAB Stock Holding History

National Bank of Canada’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Hold
2
– – ﹤0.01% 2927
2025
Q4 		$3 Buy
+2
New +$3 ﹤0.01% 2862

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

National Bank of Canada's LAB Position: Q1 2026 in Review

National Bank of Canada held its Standard BioTools (LAB) position steady in Q1 2026 at 2 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

National Bank of Canada first reported a position in LAB in Q4 2025 and has held it in 2 quarters since. The position peaked at $3 in Q4 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • National Bank of Canada held 2 shares of Standard BioTools worth $2 as of Q1 2026.
  • National Bank of Canada left its Standard BioTools share count unchanged in Q1 2026.
  • Standard BioTools made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2927 holding.
  • National Bank of Canada first reported a position in Standard BioTools in Q4 2025 and has held it in 2 quarters since.
  • National Bank of Canada's Standard BioTools position peaked at $3 in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.